Treatment for Lymphoma
Phase-Based Progress Estimates
Effectiveness
Safety
Lymphoma
Eligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will compare two types of chemotherapy to see which is more effective in treating primary CNS B-cell lymphoma.
Treatment Effectiveness
Effectiveness Progress
Other trials for Lymphoma
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: Up to 10 years
Up to 10 years
event free survival
number of participants with treatment-related adverse events as assessed by CTCAE v4.0
overall survival
progression free survival
Trial Safety
Safety Progress
This is further along than 68% of similar trials
Other trials for Lymphoma
Trial Design
0 Treatment Group
113 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 10 years
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
12,990 Previous Clinical Trials
41,297,525 Total Patients Enrolled
1,337 Trials studying Lymphoma
380,516 Patients Enrolled for Lymphoma
Alliance for Clinical Trials in OncologyLead Sponsor
497 Previous Clinical Trials
214,563 Total Patients Enrolled
53 Trials studying Lymphoma
7,069 Patients Enrolled for Lymphoma
Tracy Batchelor, MD, MPHStudy ChairMassachusetts General Hospital
4 Previous Clinical Trials
435 Total Patients Enrolled
2 Trials studying Lymphoma
12 Patients Enrolled for Lymphoma
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:Patients must have no prior chemotherapy or radiation therapy for lymphoma.
Documentation of Disease: Diagnosis of primary CNS diffuse large B-cell lymphoma confirmed by one of the following: brain biopsy or resection, cerebrospinal fluid and vitreous fluid.
Patients must have no evidence or history of NHL outside of CNS.
You must be between the ages of 18 and 75 years.
You are a patient who has received a transplant or is on immunosuppressant therapy.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Top Oncology Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments